Vox speaks with Deborah Zarin, the director of ClinicalTrials.gov.
The Wall Street Journal looks into financial ties between medical device makers and experts on FDA review panels.
NPR examines the issue of cell line contamination.
In PNAS this week: uropathogenic Escherichia coli fitness genes, terpene diversity, and more.
Science's Jennifer Couzin-Frankel details her own journey through genetic testing.
A university in Saudi Arabia appears to be recruiting highly cited researchers as adjunct professors to bolster its rankings.
BlackBerry and NantHealth have developed a cancer genome browser for a smartphone.
In PLOS this week: cross-omic study of white rot fungus, update to Paracoccidioides genome, and more.
James Watson's Nobel Prize fetches a record $4.1 million at auction.
Technology Review examines who owns the CRISPR/Cas9 gene editing approach.
In Science this week: sequencing as cost-effective way to identify intellectual disability and autism in children, more.
The National Institutes of Health is proposing a policy that says multi-site clinical studies should use a single institutional review board.
Researchers report in Nature that XNAs can have enzymatic activity.
In Nature this week: results from the African Genome Variation Project, and more.
Subscribers will be able to share read-only copies of Nature articles, the journal publisher has announced. And take our related poll.
Alan Alda's latest science communication challenge is to explain what sleep is.
Science Friday examines whether clinicians should inform family members of a person found to have a genetic risk of disease that they may also be at risk, and more.
In Genome Biology this week: sequencing study of an extensively drug-resistant case of tuberculosis, genomics infrastructure in Africa, and more.
The Scientist has compiled a list of the top life science products of the year.
According to the security firm FireEye, a new type of hacker has been after publicly traded health care and pharmaceutical companies.
The Broad Institute's Pardis Sabeti is using genome sequencing to study viruses like Ebola and Lassa, the New York Times reports.
In PNAS this week: pod shattering QTL in soybean, transcriptomic shifts in response to territory intrusions, and more.
DNA plasmids survived a trip into space, researchers from Germany and Switzerland report.
The European Commission president has suggested transferring some Horizon 2020 funds to a new investment fund.
Shinya Yamanaka and his colleagues have examined genome editing of patient-derived iPS cells to restore full-length dystrophin.
Finding a job in the sciences can be a challenge, writes Bryan Gaensler at the Conversation.
Graduate students in India are protesting their low pay.
A study of hiring patterns appearing in Science Advances finds that institutional prestige of where someone got their PhD affects where they land a faculty position.
Twitter may not just be a land of over-sharing and self-promotion, but also a place to grow scientific contacts and possibly land a job, Nature reports.